Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Avaxim vacc inj 0.5ml pre-filled syringes
140400030BCAAAD
|
Avaxim | Hepatitis A | Immunological Products and Vaccines | 60,901 |
|
Havrix Monodose vacc inj 1ml pre-filled syringes
140400030BBACAC
|
Havrix | Hepatitis A | Immunological Products and Vaccines | 25,026 |
|
Havrix Junior Monodose vacc inj 0.5ml pre-filled syringes
140400030BBADAD
|
Havrix | Hepatitis A | Immunological Products and Vaccines | 10,453 |
|
Avaxim Junior vacc inj 0.5ml pre-filled syringes
140400030BCABAD
|
Avaxim | Hepatitis A | Immunological Products and Vaccines | 7,693 |
|
VAQTA Adult vacc inj 1ml pre-filled syringes
140400030BDABAC
|
VAQTA | Hepatitis A | Immunological Products and Vaccines | 2,992 |
|
VAQTA Paediatric vacc inj 0.5ml pre-filled syringes
140400030BDAAAD
|
VAQTA | Hepatitis A | Immunological Products and Vaccines | 2,009 |
|
Hepatitis A vaccine (inactivated, adsorbed) inj 1ml pfs
140400030AAACAC
|
Hepatitis A | Hepatitis A | Immunological Products and Vaccines | 270 |
|
Hepatitis A vaccine (inactivated, adsorbed) inj 0.5ml pfs
140400030AAADAD
|
Hepatitis A | Hepatitis A | Immunological Products and Vaccines | 69 |
|
Havrix Junior Monodose vacc inj 0.5ml vials
140400030BBAFAJ
|
Havrix | Hepatitis A | Immunological Products and Vaccines | 23 |
|
Havrix Monodose vaccine suspension for injection 1ml vials
140400030BBAEAK
|
Havrix | Hepatitis A | Immunological Products and Vaccines | 10 |
|
VAQTA Adult vaccine suspension for injection 1ml vials
140400030BDADAK
|
VAQTA | Hepatitis A | Immunological Products and Vaccines | 7 |
|
Hepatitis A vacc (inactivated, adsorbed) inj 1ml vials
140400030AAAKAK
|
Hepatitis A | Hepatitis A | Immunological Products and Vaccines | 4 |
|
Epaxal vacc inj 0.5ml pre-filled syringes
140400030BEAAAI
|
Epaxal | Hepatitis A | Immunological Products and Vaccines | No data available |
|
Hepatitis A vacc (inactivated, adsorbed) inj 0.5ml pfs
140400030AAAIAI
|
Hepatitis A | Hepatitis A | Immunological Products and Vaccines | No data available |
|
Hepatitis A vacc (inactivated, adsorbed) inj 0.5ml vials
140400030AAAJAJ
|
Hepatitis A | Hepatitis A | Immunological Products and Vaccines | No data available |
|
VAQTA Paediatric vacc inj 0.5ml vials
140400030BDACAJ
|
VAQTA | Hepatitis A | Immunological Products and Vaccines | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.